Silence Therapeutics Plc - ADR
NASDAQ:SLN 4:00:00 PM EDT
| Market Cap (Intraday) | 843.79M |
| Current PE | N/A |
| Forward PE | N/A |
| 2yr Forward PE | N/A |
| 10-Day MA | $18.48 |
| 50-Day MA | $18.04 |
| 200-Day MA | $20.34 |
Silence Therapeutics Plc - ADR Stock, NASDAQ:SLN
72 Hammersmith Road, London, Greater London W14 8TH
United Kingdom
Phone: +44.20.3457.6900
Number of Employees: 109
Description
Silence Therapeutics Plc engages in the discovery, delivery, and development of ribonucleic acid (RNA) therapeutics. It also develops medicines by harnessing the body's natural mechanism of RNA interference within its cells. The company was founded on November 18, 1994 and is headquartered in London, the United Kingdom.